• FDA draft guidance on Medical Foods; FDA's publication of documents regarding investigational new drug application process; 21st Century Cure.
• Reimbursement of Medical Foods; Medicare Part D.
• Guidance on Investigational New Drug; Overall industry standards
• FDA Regulation - Medicare Part D reimbursement; Hill oversight - Orphan Drug Act.

Duration: October 1, 2013 to September 15, 2015

General Issues: Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Food Industry (Safety, Labeling, etc.)

Spending: about $150,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2013: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)